Tate & Lyle agrees £2.7bn takeover by US rival in new blow to London market
Tate & Lyle has agreed to a £2.7bn takeover by Chicago-based Ingredion, lifting its shares and putting about 475 jobs at risk.
Intelligence analysis by GPT-5.4 Mini
The British ingredients maker is being bought by a US rival after years of weak share performance. The deal could reshape the business, but it also adds to concerns about London-listed companies being taken over or leaving the market.
Tate & Lyle is like a small shop that makes special ingredients for food. A bigger American company wants to buy it, which may help the business grow, but some workers could lose their jobs.
Analysis
Deal terms
Tate & Lyle has agreed to be bought by Ingredion in a deal valued at about £2.7bn. The offer values Tate & Lyle at 615p a share, roughly 60% above its price before takeover speculation surfaced, which explains why the stock jumped sharply in early trading.
Why the company is vulnerable
Tate & Lyle is one of the oldest listed companies in the UK, but its share price had fallen heavily before the deal was announced, losing more than half its value over five years. The company had already shifted away from its old sugar business, selling that division in 2010 and later focusing on artificial sweeteners and specialty ingredients. It bought CP Kelco in 2024 to deepen that strategy, but the article says investors were still not convinced, with weak consumer demand weighing on sentiment despite the rise of GLP-1 weight loss drugs.
Job and market impact
The companies said the transaction could lead to a “material reduction” in Tate & Lyle’s workforce. That would be about 475 jobs, or 3% of the combined group’s headcount. Tate & Lyle has just under 5,000 staff worldwide, including about 200 in the UK, most of them in London. Ingredion employs about 11,000 people globally.
Bigger picture
For London markets, the deal is another sign of pressure. The Guardian notes that several London-listed companies have already agreed to take-private deals this year, including Schroders, Beazley and Intertek. Tate & Lyle’s chair, David Hearn, argued the new group would have greater scale and more room for innovation, while Ingredion’s Jim Zallie said the combination would create a global leader in ingredient solutions.
Key points
- Tate & Lyle has agreed to a £2.7bn takeover by US rival Ingredion.
- The offer values the company at 615p per share, about 60% above its pre-bid price.
- The companies say the deal could put about 475 jobs, or 3% of the combined workforce, at risk.
- Tate & Lyle’s shares had fallen by more than half over five years before the bid.
- The deal is the latest in a series of high-profile exits from the London market.
If the takeover goes through as planned, Tate & Lyle’s products could gain from Ingredion’s bigger size, wider reach, and more money for investment. The companies say the combined business would have greater scale and stronger innovation for customers.
The article says the deal could lead to a material reduction in the workforce, with about 475 jobs at risk. It also adds to the pattern of London-listed firms being absorbed or taken private, which could further weaken confidence in the market.
